Ahrens Investment Partners’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $18.1K | Buy |
+400
| New | +$18.1K | 0.01% | 482 |
|
|
2022
Q3 | – | Sell |
-65
| Closed | -$4K | – | 309 |
|
|
2022
Q2 | $4K | Hold |
65
| – | – | ﹤0.01% | 787 |
|
|
2022
Q1 | $4K | Hold |
65
| – | – | ﹤0.01% | 864 |
|
|
2021
Q4 | $5K | Buy |
+65
| New | +$5K | ﹤0.01% | 869 |
|
|
2021
Q1 | – | Sell |
-1,685
| Closed | -$258K | – | 216 |
|
|
2020
Q4 | $258K | Buy |
+1,685
| New | +$258K | 0.14% | 141 |
|
|
2018
Q3 | – | Sell |
-3,415
| Closed | -$201K | – | 177 |
|
|
2018
Q2 | $201K | Buy |
+3,415
| New | +$201K | 0.08% | 154 |
|